Omeros Corporation (OMER) Stock Price

11.64 ▼ -0.34 (-2.84%)
Open: 11.54 Vol: 710.15K Day's range: 11.22 - 11.76 Mar 03, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
OMER Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL NEUTRAL BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 11.65▼ 11.66▼ 11.59▲ 11.72▼ 11.73▼
MA10 11.65▼ 11.57▲ 11.64▼ 11.74▼ 12.31▼
MA20 11.67▼ 11.67▼ 11.73▼ 11.57▲ 10.87▲
MA50 11.59▲ 11.68▼ 11.59▲ 12.36▼ 7.17▲
MA100 11.61▲ 11.62▼ 11.64▼ 10.28▲ 6.59▲
MA200 11.73▼ 11.62▼ 11.68▼ 7.04▲ 5.17▲
  5 mins 30 mins Hourly Daily Weekly
MACD -0.011▼ 0.008▲ -0.024▼ 0.046▲ -0.173▼
RSI 46.616▼ 48.399▼ 48.644▼ 48.477▼ 57.840▲
STOCH 40.256     77.326     38.170     48.663     30.390    
WILL %R -92.308▼ -50.000     -56.471     -55.862     -64.072    
CCI -86.084     47.246     -23.873     -42.303     -24.028    
Latest Filters Detected On OMER
RSI $OMER RSI(14) Crossed Below 50 Set Alert
MA $OMER Price Crossed Below MA(26) Set Alert
MA $OMER Price Crossed Below MA(13) Set Alert
MA $OMER Price Crossed Below MA(7) Set Alert
▼ GAP $OMER Open Gap Down %3 Set Alert
▼ GAP $OMER Open Gap Down %2 Set Alert
Omeros Corporation News
Omeros Announces Successful Primate Study in OncotoX-AML™ Drug Program
Tuesday, February 17, 2026 06:17 AM
Omeros Corporation (NASDAQ: OMER) today announced the successful completion of its initial study in nonhuman primates evaluating the efficacy and safety of its OncotoX-AML cancer therapeutic platform.
Why Omeros Stock Skyrocketed Today
Wednesday, December 24, 2025 02:41 PM
It won approval for a medicine that treats a potentially fatal complication from stem cell transplants. This is the first drug approved for that indication. 10 stocks we like better than Omeros › For ...
OMER Surges 81% On FDA Approval Of Yartemlea For Transplant-Related TA-TMA
Wednesday, December 24, 2025 09:05 AM
(RTTNews) - Omeros Corporation (OMER) jumped 81.14%, closing at $15.85, up $7.10, after the U.S. FDA approved Yartemlea (narsoplimab-wuug) for the treatment of transplant-associated thrombotic ...
OMER historical stock data
date open high low close volume
03/03/26 11.54 11.76 11.22 11.64 710,146
02/03/26 11.79 12.13 11.67 11.98 896,137
27/02/26 11.37 12.075 11.37 12.05 1,205,919
26/02/26 11.38 11.58 11.28 11.55 537,888
25/02/26 11.60 11.78 11.31 11.38 687,669
24/02/26 11.37 11.83 11.36 11.55 866,371
23/02/26 11.96 12.13 11.09 11.44 0
20/02/26 11.86 12.22 11.73 12.04 1,007,423
19/02/26 11.62 12.15 11.62 12.01 728,844
18/02/26 11.87 12.24 11.66 11.75 840,450
Quote Details
52wk Low:2.95
52wk High:17.65
Vol:710.15K
Avg Vol(3m):23.8M
1Y Chng:+29.62%
1M Chng:-5.06%
Add to Watch List
More Information
Index US Composite
Market Cap. 849.39M